Home Applications 021065 Application 021065
Type NDA
Sponsor APIL Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 FEMHRT ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL 0.0025MG;0.5MG No No 002 FEMHRT ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021065-001 FEMHRT ETHINYL ESTRADIOL; NORETHINDRONE ACETATE 0.0025MG;0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2005-01-14 N021065-002 FEMHRT ETHINYL ESTRADIOL; NORETHINDRONE ACETATE 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021065-002 FEMHRT 0.005MG;1MG TABLET / ORAL RLD 1999-10-15 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021065-002 FEMHRT 0.005MG;1MG TABLET / ORAL RLD 1999-10-15 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL AB 2005-01-14 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET / ORAL RLD 1999-10-15 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-10-15 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021065-001 FEMHRT 0.0025MG;0.5MG TABLET / ORAL RLD 2005-01-14 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021065-002 FEMHRT 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET / ORAL RLD 1999-10-15 782e0a99824c…
Observed Orange Book normalized TE history# NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0430-0145 femhrt norethindrone acetate/ethinyl estradiol Allergan, Inc. NDA Current 0430-0145 femhrt norethindrone acetate/ethinyl estradiol Allergan, Inc. NDA Current 52544-236 Jevantique Lo Norethindrone Acetate and Ethinyl Estradiol Actavis Pharma, Inc. NDA Current